Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.

Ewer K, Sebastian S, Spencer AJ, Gilbert S, Hill AVS, Lambe T.

Hum Vaccin Immunother. 2017 Dec 2;13(12):3020-3032. doi: 10.1080/21645515.2017.1383575. Epub 2017 Oct 30. Review.

2.

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™.

Venkatraman N, Anagnostou N, Bliss C, Bowyer G, Wright D, Lövgren-Bengtsson K, Roberts R, Poulton I, Lawrie A, Ewer K, V S Hill A.

Vaccine. 2017 Oct 27;35(45):6208-6217. doi: 10.1016/j.vaccine.2017.09.028. Epub 2017 Sep 21.

PMID:
28941620
3.

Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.

Milligan ID, Gibani MM, Sewell R, Clutterbuck EA, Campbell D, Plested E, Nuthall E, Voysey M, Silva-Reyes L, McElrath MJ, De Rosa SC, Frahm N, Cohen KW, Shukarev G, Orzabal N, van Duijnhoven W, Truyers C, Bachmayer N, Splinter D, Samy N, Pau MG, Schuitemaker H, Luhn K, Callendret B, Van Hoof J, Douoguih M, Ewer K, Angus B, Pollard AJ, Snape MD.

JAMA. 2016 Apr 19;315(15):1610-23. doi: 10.1001/jama.2016.4218.

PMID:
27092831
4.

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.

Longley RJ, Salman AM, Cottingham MG, Ewer K, Janse CJ, Khan SM, Spencer AJ, Hill AVS.

Sci Rep. 2015 Jul 3;5:11820. doi: 10.1038/srep11820.

5.

Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults.

Ogwang C, Kimani D, Edwards NJ, Roberts R, Mwacharo J, Bowyer G, Bliss C, Hodgson SH, Njuguna P, Viebig NK, Nicosia A, Gitau E, Douglas S, Illingworth J, Marsh K, Lawrie A, Imoukhuede EB, Ewer K, Urban BC, Hill AVS, Bejon P; MVVC group.

Sci Transl Med. 2015 May 6;7(286):286re5. doi: 10.1126/scitranslmed.aaa2373.

6.

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

Ewer K, Rampling T, Venkatraman N, Bowyer G, Wright D, Lambe T, Imoukhuede EB, Payne R, Fehling SK, Strecker T, Biedenkopf N, Krähling V, Tully CM, Edwards NJ, Bentley EM, Samuel D, Labbé G, Jin J, Gibani M, Minhinnick A, Wilkie M, Poulton I, Lella N, Roberts R, Hartnell F, Bliss C, Sierra-Davidson K, Powlson J, Berrie E, Tedder R, Roman F, De Ryck I, Nicosia A, Sullivan NJ, Stanley DA, Mbaya OT, Ledgerwood JE, Schwartz RM, Siani L, Colloca S, Folgori A, Di Marco S, Cortese R, Wright E, Becker S, Graham BS, Koup RA, Levine MM, Volkmann A, Chaplin P, Pollard AJ, Draper SJ, Ballou WR, Lawrie A, Gilbert SC, Hill AV.

N Engl J Med. 2016 Apr 28;374(17):1635-46. doi: 10.1056/NEJMoa1411627. Epub 2015 Jan 28.

7.

Viral vectors as vaccine platforms: deployment in sight.

Rollier CS, Reyes-Sandoval A, Cottingham MG, Ewer K, Hill AV.

Curr Opin Immunol. 2011 Jun;23(3):377-82. doi: 10.1016/j.coi.2011.03.006. Epub 2011 Apr 20. Review.

PMID:
21514130
8.

Prime-boost vectored malaria vaccines: progress and prospects.

Hill AV, Reyes-Sandoval A, O'Hara G, Ewer K, Lawrie A, Goodman A, Nicosia A, Folgori A, Colloca S, Cortese R, Gilbert SC, Draper SJ.

Hum Vaccin. 2010 Jan;6(1):78-83. Epub 2010 Jan 18. Review.

9.

Potency assays for novel T-cell-inducing vaccines against malaria.

Reyes-Sandoval A, Pearson FE, Todryk S, Ewer K.

Curr Opin Mol Ther. 2009 Feb;11(1):72-80. Review.

PMID:
19169962
10.

Gene expression profiling and antigen mining of the tuberculin production strain Mycobacterium bovis AN5.

Garcia Pelayo MC, Garcia JN, Golby P, Pirson C, Ewer K, Vordermeier M, Hewinson RG, Gordon SV.

Vet Microbiol. 2009 Jan 13;133(3):272-7. doi: 10.1016/j.vetmic.2008.07.004. Epub 2008 Jul 25.

PMID:
18760551
11.

Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complex.

Sidders B, Pirson C, Hogarth PJ, Hewinson RG, Stoker NG, Vordermeier HM, Ewer K.

Infect Immun. 2008 Sep;76(9):3932-9. doi: 10.1128/IAI.00150-08. Epub 2008 Jun 2.

12.

Characterization of two in vivo-expressed methyltransferases of the Mycobacterium tuberculosis complex: antigenicity and genetic regulation.

Golby P, Nunez J, Cockle PJ, Ewer K, Logan K, Hogarth P, Vordermeier HM, Hinds J, Hewinson RG, Gordon SV.

Microbiology. 2008 Apr;154(Pt 4):1059-67. doi: 10.1099/mic.0.2007/014548-0.

13.

T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection.

Richeldi L, Ewer K, Losi M, Bergamini BM, Millington K, Fabbri LM, Lalvani A.

Pediatrics. 2007 Jan;119(1):e1-5.

PMID:
17200234
14.

Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice.

Gooding S, Chowdhury O, Hinks T, Richeldi L, Losi M, Ewer K, Millington K, Gunatheesan R, Cerri S, McNally J, Lalvani A.

J Infect. 2007 Mar;54(3):e169-74. Epub 2006 Dec 22.

15.

Implanon and alopecia.

Lee DJ, Ewer K.

J Fam Plann Reprod Health Care. 2006 Oct;32(4):255. No abstract available.

16.

Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis.

Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A.

Am J Respir Crit Care Med. 2006 Oct 1;174(7):831-9. Epub 2006 Jun 23.

PMID:
16799072
17.

Repeated tuberculin testing does not induce false positive ELISPOT results.

Richeldi L, Ewer K, Losi M, Roversi P, Fabbri LM, Lalvani A.

Thorax. 2006 Feb;61(2):180. No abstract available.

18.

Antigen mining with iterative genome screens identifies novel diagnostics for the Mycobacterium tuberculosis complex.

Ewer K, Cockle P, Gordon S, Mansoor H, Govaerts M, Walravens K, Marché S, Hewinson G, Vordermeier M.

Clin Vaccine Immunol. 2006 Jan;13(1):90-7.

19.

Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells.

Richeldi L, Luppi M, Losi M, Luppi F, Potenza L, Roversi P, Cerri S, Millington KA, Ewer K, Fabbri LM, Torelli G, Lalvani A.

Leukemia. 2006 Feb;20(2):379-81. No abstract available.

PMID:
16357840
20.

Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study.

Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ, Efe S, Staveley I, Ewer K, Lalvani A.

Lancet. 2005 Oct 22-28;366(9495):1443-51.

PMID:
16243089

Supplemental Content

Loading ...
Support Center